BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu F, Liao Z, Song J, Yuan C, Liu Y, Zhang H, Pan Y, Zhang Z, Zhang B. Genome-wide screening diagnostic biomarkers and the construction of prognostic model of hepatocellular carcinoma. J Cell Biochem 2020;121:2582-94. [PMID: 31692036 DOI: 10.1002/jcb.29480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Liu F, Qin L, Liao Z, Song J, Liang H, Chen X, Zhang Z, Zhang B. Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma. BMC Gastroenterol 2021;21:284. [PMID: 34247571 DOI: 10.1186/s12876-021-01869-4] [Reference Citation Analysis]
2 Ren K, Ma J, Zhou B, Lin X, Hou M, Zhang L, Yuan L, Ma J. Identification of prognostic and immune-related lncRNAs in hepatocellular carcinoma based on the cancer genome atlas data mining. mat express 2020;10:1189-96. [DOI: 10.1166/mex.2020.1736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Feng Z, Li B, Chen Q, Zhang H, Guo Z, Qin J, Zhang Z. Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma. Journal of Oncology 2022;2022:1-24. [DOI: 10.1155/2022/9054983] [Reference Citation Analysis]
4 Huo J, Wu L, Zang Y. Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma. J Clin Transl Hepatol 2021;9:169-79. [PMID: 34007798 DOI: 10.14218/JCTH.2020.00114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wu D, Pan Y, Zheng X. Identification of hub genes-based predictive model in hepatocellular carcinoma by robust rank aggregation and regression analysis. J Cancer 2021;12:1884-93. [PMID: 33753986 DOI: 10.7150/jca.52089] [Reference Citation Analysis]
6 Huo J, Wu L, Zang Y. Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma. J Cell Mol Med 2021;25:1151-65. [PMID: 33300278 DOI: 10.1111/jcmm.16181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yuan P, Ling L, Gao X, Sun T, Miao J, Yuan X, Liu J, Wang Z, Liu B. Identification of RNA-binding protein SNRPA1 for prognosis in prostate cancer. Aging (Albany NY) 2021;13:2895-911. [PMID: 33460399 DOI: 10.18632/aging.202387] [Reference Citation Analysis]
8 Pan X, Li M, Huang L, Mo D, Liang Y, Huang Z, Zhu B, Fang M. CD44, IL-33, and ST2 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility in the Chinese Population. Biomed Res Int 2020;2020:2918517. [PMID: 33062675 DOI: 10.1155/2020/2918517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu H, Xie Y, Sun Y, Guo R, Lv D, Li X, Li F, He M, Fan Y, Deng D. Integrated analysis of multiple microarray studies to identify potential pathogenic gene modules in preeclampsia. Exp Mol Pathol 2021;120:104631. [PMID: 33744280 DOI: 10.1016/j.yexmp.2021.104631] [Reference Citation Analysis]